- Home
- TMO vs PM Comparison
TMO vs PM Comparison
Compare TMO & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMO
- PM
- Stock Information
- Founded
- TMO 1956
- PM 1987
- Country
- TMO United States
- PM United States
- Employees
- TMO N/A
- PM N/A
- Industry
- TMO Industrial Machinery/Components
- PM Medicinal Chemicals and Botanical Products
- Sector
- TMO Industrials
- PM Health Care
- Exchange
- TMO Nasdaq
- PM Nasdaq
- Market Cap
- TMO 216.4B
- PM 238.8B
- IPO Year
- TMO N/A
- PM N/A
- Fundamental
- Price
- TMO $592.32
- PM $156.87
- Analyst Decision
- TMO Buy
- PM Strong Buy
- Analyst Count
- TMO 17
- PM 9
- Target Price
- TMO $611.19
- PM $190.44
- AVG Volume (30 Days)
- TMO 1.7M
- PM 5.7M
- Earning Date
- TMO 10-22-2025
- PM 10-21-2025
- Dividend Yield
- TMO 0.29%
- PM 3.76%
- EPS Growth
- TMO 8.54
- PM N/A
- EPS
- TMO 17.32
- PM 5.52
- Revenue
- TMO $43,736,000,000.00
- PM $39,992,000,000.00
- Revenue This Year
- TMO $4.28
- PM $10.72
- Revenue Next Year
- TMO $5.00
- PM $7.66
- P/E Ratio
- TMO $34.26
- PM $28.34
- Revenue Growth
- TMO 3.22
- PM 7.45
- 52 Week Low
- TMO $385.46
- PM $116.12
- 52 Week High
- TMO $610.97
- PM $186.69
- Technical
- Relative Strength Index (RSI)
- TMO 65.64
- PM 54.76
- Support Level
- TMO $556.46
- PM $150.09
- Resistance Level
- TMO $602.32
- PM $158.23
- Average True Range (ATR)
- TMO 14.02
- PM 3.35
- MACD
- TMO -0.22
- PM 0.62
- Stochastic Oscillator
- TMO 80.42
- PM 87.25
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.